The latest research progress of metformin on the effect beyond hypoglycemic

Lili Deng, Xiaotong Zhao
{"title":"The latest research progress of metformin on the effect beyond hypoglycemic","authors":"Lili Deng, Xiaotong Zhao","doi":"10.3760/CMA.J.ISSN.1008-6315.2019.06.021","DOIUrl":null,"url":null,"abstract":"Objective \nMetformin (MET) is the first-line medications of choice for patients with type 2 diabetes.In recent years, a large number of studies at home and abroad have shown that metformin not only has significant effects in controlling blood sugar level of diabetic patients and intervening in impaired glucose tolerance, but also has \" magical\" effects in in the field of hypoglycemic outside.In addition to the early discovery that metformin can be used to treat metabolic syndrome and polycystic ovary syndrome, control body weight, blood pressure, blood lipid, and reduce the risk of cardiovascular events, metformin can also play anti-tumor, anti-inflammatory effects, delay aging, and treat mental disorders such as depression.This article reviews the effect of metformin in the field out of hypoglycemic. \n \n \nKey words: \nMetformin; Neuropsychiatric disorders; Intestinal flora; Osteogenesis; Anti-inflammatory and anti-aging","PeriodicalId":10365,"journal":{"name":"中国综合临床","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国综合临床","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1008-6315.2019.06.021","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective Metformin (MET) is the first-line medications of choice for patients with type 2 diabetes.In recent years, a large number of studies at home and abroad have shown that metformin not only has significant effects in controlling blood sugar level of diabetic patients and intervening in impaired glucose tolerance, but also has " magical" effects in in the field of hypoglycemic outside.In addition to the early discovery that metformin can be used to treat metabolic syndrome and polycystic ovary syndrome, control body weight, blood pressure, blood lipid, and reduce the risk of cardiovascular events, metformin can also play anti-tumor, anti-inflammatory effects, delay aging, and treat mental disorders such as depression.This article reviews the effect of metformin in the field out of hypoglycemic. Key words: Metformin; Neuropsychiatric disorders; Intestinal flora; Osteogenesis; Anti-inflammatory and anti-aging
二甲双胍除降糖外作用的最新研究进展
目的二甲双胍(Metformin, MET)是2型糖尿病患者首选的一线药物。近年来,国内外大量研究表明,二甲双胍不仅在控制糖尿病患者血糖水平、干预糖耐量受损方面有显著效果,而且在降糖领域外也有“神奇”的作用。除了早期发现二甲双胍可用于治疗代谢综合征和多囊卵巢综合征,控制体重、血压、血脂,降低心血管事件发生风险外,二甲双胍还可起到抗肿瘤、抗炎、延缓衰老、治疗抑郁症等精神障碍等作用。本文综述了二甲双胍在降糖领域的作用。关键词:二甲双胍;神经精神障碍;肠道菌群;骨生成;抗炎抗衰老
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.10
自引率
0.00%
发文量
16855
期刊介绍: Clinical Medicine of China is an academic journal organized by the Chinese Medical Association (CMA), which mainly publishes original research papers, reviews and commentaries in the field. Clinical Medicine of China is a source journal of Peking University (2000 and 2004 editions), a core journal of Chinese science and technology, an academic journal of RCCSE China Core (Extended Edition), and has been published in Chemical Abstracts of the United States (CA), Abstracts Journal of Russia (AJ), Chinese Core Journals (Selection) Database, Chinese Science and Technology Materials Directory, Wanfang Database, China Academic Journal Database, JST Japan Science and Technology Agency Database (Japanese) (2018) and other databases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信